Evidence map›Paper›PMID 37028912›Full record

ArticleOpen heart2023

Temporal trends in the incidence of infective endocarditis in patients with a prosthetic heart valve.

Katra Hadji-Turdeghal, Andreas Dalsgaard Jensen, Niels Eske Bruun, Kasper Karmark Iversen, Henning Bundgaard, Morten Smerup, Lars Kober, Lauge Østergaard, Emil Loldrup Fosbøl

Abstract read
In one paragraph

Article in Open heart, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Contemporary Features and Management of Endocarditis.Diagnostics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katra Hadji-TurdeghalDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark katra.hadji-turdeghal@regionh.dk.ORCID 0000-0003-3763-6777
Andreas Dalsgaard JensenDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Niels Eske BruunDepartment of Cardiology, Zealand University Hospital Roskilde, Roskilde, Denmark.
Kasper Karmark IversenDepartment of Emergency Medicine, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Henning BundgaardDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Morten SmerupDepartment of Cardiothoracic Surgery, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Lars KoberDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
Lauge ØstergaardDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-3298-1467
Emil Loldrup FosbølDepartment of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe incidence of infective endocarditis (IE) is increasing, as is the insertion of prosthetic heart valves. We aimed to examine nationwide temporal trends in the incidence of IE in patients with a prosthetic heart valve in Denmark from 1999 to 2018.

methodsUsing the Danish nationwide registries, we identified patients who underwent heart valve implantation (for other reasons than IE) between 1999 and 2018. Crude incidence rates of IE per 1000 person-years (PY) were computed in 2-year intervals. IE incidences were compared using sex-adjusted and age-adjusted incidence rate ratios (IRR) using Poisson regression across calendar periods (1999-2003, 2004-2008, 2009-2013, and 2014-2018).

resultsWe identified 26 604 patients with first-time prosthetic valve implantation (median age 71.7 years (IQR 62.7-78.0), 63% males). The median follow-up time was 5.4 years (IQR 2.4-9.6). Patients in the time period 2014-2018 were older (median age of 73.9 years (66.2:80.3)), and with a higher burden of comorbidities compared with the time period 1999-2003 (median age of 67.9 years (58.3:74.5)) at the time of implantation. A total of 1442 (5.4%) patients developed IE. The lowest IE incidence rate was 5.4/1000 PY (95% CI 3.9 to 7.4) in 2001-2002, and the highest incidence rate was 10.0/1000 PY (95% CI 8.8 to 11.1) in 2017-2018 with an unadjusted increase during the study period (p=0.003). We found an adjusted IRR of 1.04 (95% CI 1.02 to 1.06) (p<0.0007) per two calendar-years increments. Age-adjusted IRR for men were 1.04 (95% CI 1.01 to 1.07) (p=0.002) per two calendar years increment, and for women 1.03 (95% CI 0.99 to 1.07) (p=0.12), with p=0.32 for interaction.

conclusionIn Denmark, the incidence of IE increased during the last 20 years in patients with prosthetic heart valves.

Indexed as

EndocarditisHeart Valve ProsthesisHeart Valve Prosthesis ImplantationAgedChild, PreschoolFemaleHumansIncidenceMaleRisk FactorsEndocarditisHeart Valve ProsthesisHeart Valve Prosthesis Implantation

Identifiers

PMID37028912
PMCPMC10083846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.